BioScrip to Present at the Jefferies 2017 Global Healthcare Conference
May 24, 2017 12:03 pm UTC| Business
DENVER, May 24, 2017 -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), a leading national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf, President and...
Atara Biotherapeutics to Present at Three Upcoming Investor Conferences
May 24, 2017 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 24, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA) today announced that the Company will present at three upcoming investor conferences in June: Jefferies 2017 Global Healthcare...
Atara Biotherapeutics to Present at Three Upcoming Investor Conferences
May 24, 2017 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 24, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA) today announced that the Company will present at three upcoming investor conferences in June: Jefferies 2017 Global Healthcare...
Atara Biotherapeutics to Present at Three Upcoming Investor Conferences
May 24, 2017 12:02 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 24, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA) today announced that the Company will present at three upcoming investor conferences in June: Jefferies 2017 Global Healthcare...
TRACON Doses First Patient in Phase 1/2 Study of TRC253 in Patients with Prostate Cancer
May 24, 2017 12:02 pm UTC| Business
SAN DIEGO, May 24, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
TRACON Doses First Patient in Phase 1/2 Study of TRC253 in Patients with Prostate Cancer
May 24, 2017 12:02 pm UTC| Business
SAN DIEGO, May 24, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
TRACON Doses First Patient in Phase 1/2 Study of TRC253 in Patients with Prostate Cancer
May 24, 2017 12:02 pm UTC| Business
SAN DIEGO, May 24, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...